A Study of GNC-077 in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer and Other Solid Tumors

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 16, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions

Non-small Cell Lung CancerSolid Tumor

Interventions

DRUG

GNC-077

Administration by intravenous infusion for a cycle of 3 weeks.

Trial Locations (1)

RECRUITING

Shanghai East Hospital, Shanghai

All Listed Sponsors

collaborator

Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.

INDUSTRY

lead

Sichuan Baili Pharmaceutical Co., Ltd.

INDUSTRY